
Denis Chem Lab Announces 45th AGM and Annual Report 2025-26
Denis Chem Lab Ltd has issued a notice for its 45th Annual General Meeting (AGM) along with the Annual Report for the fiscal year 2025-26. This filing, made pursuant to SEBI (LODR) Regulations, 2015, includes the formal notice for the AGM and the comprehensive annual report detailing the company's performance and operations. The report highlights the company's vision to be a leading pharmaceutical entity and its mission to deliver high-quality medical products while ensuring shareholder returns through innovation. Key personnel, including the Board of Directors and Management Team, are listed, along with statutory auditors, secretarial auditors, cost auditors, bankers, and the registrar & transfer agents. The company also encourages members to adopt paperless compliance by registering their email addresses.
Key Highlights
- Notice issued for the 45th Annual General Meeting.
- Annual Report for FY 2025-26 is enclosed with the notice.
- Company aims to be a leading pharmaceutical firm with quality products.
- Members encouraged to register email for paperless compliance.
Price Impact
More from DENISCHEM